DM

David S. Millan

FT Forma Therapeutics: 38 patents #4 of 86Top 5%
Pfizer: 9 patents #561 of 5,153Top 15%
VH Valo Health: 5 patents #14 of 53Top 30%
VD Valo Early Discovery: 4 patents #17 of 30Top 60%
IC Icagen: 4 patents #38 of 88Top 45%
FT Foghorn Therapeutics: 3 patents #8 of 25Top 35%
VI Vertex Pharmaceuticals Incorporated: 2 patents #526 of 896Top 60%
📍 Stow, MA: #4 of 318 inventorsTop 2%
🗺 Massachusetts: #769 of 88,656 inventorsTop 1%
Overall (All Time): #37,528 of 4,157,543Top 1%
61
Patents All Time

Issued Patents All Time

Showing 51–61 of 61 patents

Patent #TitleCo-InventorsDate
9096558 N-sulfonylbenzamide compounds Benjamin Scott Greener, Brian Edward Marron, David James Rawson, Robert Ian Storer, Nigel Alan Swain 2015-08-04
8907101 Sulfonamide derivatives Serge Beaudoin, Michael Christopher Laufersweiler, Christopher John Markworth, Brian Edward Marron, David James Rawson +7 more 2014-12-09
8822439 Glucocorticoid receptor agonists Paul Alan Glossop, David Anthony Price 2014-09-02
8685977 Chemical compounds Andrew Simon Bell, Alan Daniel Brown, Russell Andrew Lewthwaite, Ian Roger Marsh, Manuel Perez Pacheco +6 more 2014-04-01
8592629 Sulfonamide derivatives as Nav 1.7 inhibitors Andrew Simon Bell, Alan Daniel Brown, Marcel John De Groot, Russell Andrew Lewthwaite, Ian Roger Marsh +6 more 2013-11-26
8541588 Sulfonamide derivatives Serge Beaudoin, Michael Christopher Laufersweiler, Christopher John Markworth, Brian Edward Marron, David James Rawson +7 more 2013-09-24
8153814 Sulfonamide derivatives Serge Beaudoin, Michael Christopher Laufersweiler, Christopher John Markworth, Brian Edward Marron, David James Rawson +7 more 2012-04-10
8129381 Caspase inhibitors and uses thereof Ronald Knegtel, Michael Mortimore, John Studley 2012-03-06
8076356 Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors John Paul Mathias, Russell Andrew Lewthwaite, Christopher Phillips 2011-12-13
7553852 Caspase inhibitors and uses thereof Ronald Knegtel, Michael Mortimore, John Studley 2009-06-30
7511057 Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors John Paul Mathias, Russell Andrew Lewthwaite, Christopher Phillips 2009-03-31